Life Sciences & MedTech Payment Performance: A Marginal Improvement in 2025 (63.1 vs 60.8)

The Comparison

Here's a snapshot of payment practices across Life Sciences and Medical Technology sectors:

• 2024: Analyzed data from 113 companies, yielding an average payment score of 60.8 out of 100.
• 2025: Analyzed data from 99 companies, showing an average payment score of 63.1 out of 100.

What This Means

While the sector demonstrates a slight increase in payment performance between 2024 and 2025, the 2.3-point improvement is relatively small, suggesting the underlying payment challenges within the industry are proving difficult to shift. This indicates consistent but slow adjustments in payment terms or efficiency in processing invoices in the sector. Use this late payment calculator to see how late payments can affect your profitability.

In a single line: Payment performance in Life Sciences & MedTech crept up from 60.8 (out of 100) across 113 firms in 2024 to 63.1 across 99 firms in 2025.